India to Myanmar: Amlodipine Export Trade Route
India has recorded 643 verified shipments of Amlodipine exported to Myanmar, representing a combined trade value of $15.7M USD. This corridor is served by 92 active Indian exporters, with an average shipment value of $24.5K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 34% of total export value with 90 shipments worth $5.4M USD. On the buying side, MYIT MAHAR TRADING CO., LTD. is the largest importer in Myanmar with $2.5M USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , LINCOLN PHARMACEUTICALS LTD — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Myanmar Amlodipine corridor is one of India's established pharmaceutical export routes, with 643 shipments documented worth a combined $15.7M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 34% of all export value, reflecting the consolidated nature of India's amlodipine manufacturing sector.
Across 92 active suppliers, the average shipment value stands at $24.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during January–March, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 10.3%, placing it at rank #1 among India's top amlodipine export destinations globally.
On the import side, key buyers of Indian amlodipine in Myanmar include MYIT MAHAR TRADING CO., LTD. , MYIT MAHAR TRADING CO., LTD., UNIVERSAL CO. LTD. and 131 others. MYIT MAHAR TRADING CO., LTD. is the single largest importer with 15 shipments valued at $2.5M USD.
